Category

News Media

Live: ‘Naive’ to think criminal element will end with pot legalization, senior Mountie tells MPs

By | Drug Policy, News Media

September 11, 2017
CBC News
Health committee hears from senior government officials, RCMP on pot legislation

LIVE Commons health committee hearing on pot legislation

A senior RCMP officer says it would be “naive” to think organized crime in the cannabis market will be eliminated with the legalization of recreational marijuana.

www.cbc.ca/news/politics/health-committee-marijuana-legalization-1.4282569

Health committee considers BILL C-45 (legalize cannabis)

By | Drug Policy, News Media

Created: September 11, 2017
Last update: September 15, 2017

Canadian Cannabis Flag

House of Commons Health Committee
considers BILL C-45
(cannabis, marijuana)


September 11, 2017 to September 15, 2017 recorded testimony on the government’s BILL C-45 (cannabis, marijuana).

Watch the hearings live on CPAC.ca

In Committee from the House of Commons Marijuana

Health committee – September 11, 2017 – Part 1
The committee reconvenes a week ahead of Parliament’s return to begin its hearings on C-45, the government’s bill to legalize marijuana. The proposed Cannabis Act would create a legal framework to control the production, distribution, sale and possession of recreational marijuana in Canada. Sales will be restricted to people age
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691406

Health committee – September 11, 2017 – Part 2
Former justice minister Anne McLellan, who chaired the federal task force on marijuana legalization, testifies as the committee continues its hearings on Bill C-45
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691427

Health committee – September 11, 2017 – Part 3
MPs continue their hearings on the government’s cannabis legislation (C-45), with a panel on provincial responsibilities and perspectives from the cannabis industry. The committee hears from Philippe Lucas (executive director, Canadian Medical Cannabis Council), Keith Jones (chair, government relations) and Robert Rae (director), both with the Canadian Hemp Trade Alliance
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691429

Health committee – September 11, 2017 – Part 4
Canadian Medical Association president Laurent Marcoux and his colleague Jeff Blackmer (vice-president of medical professionalism) are among the witnesses to testify as the committee continues its review of C-45, the federal government’s marijuana legalization bill. MPs also hear from Trevor Bhupsingh (director general, Law Enforcement and Border Strategies Directorate
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691431

Health committee – September 12, 2017 – Part 1
The following witnesses testify on Bill C-45: Thomas Carrique (deputy chief) and Mike Serr (deputy chief constable, drug advisory committee), who are all representing the Canadian Association of Chiefs of Police; Rick Barnum (deputy commissioner, investigation and organized crime) from the Ontario Provincial Police; and Mark Chatterbok (deputy chief of operations) with the Saskatoon Police Service
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691441

Health committee – September 12, 2017 – Part 2
The committee discusses justice and public safety issues as it continues its hearings on the government’s marijuana legislation (C-45). MPs hear from Neil Boyd (criminology professor, Simon Fraser University); Christian Leuprecht (political science professor, Royal Military College of Canada); Barreau du Québec representatives Paul-Matthieu Grondin (president), Luc Hervé Thibaudeau
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691461

Health committee – September 12, 2017 – Part 3
The committee hears about the experiences of other jurisdictions as it continues its review of the government’s marijuana legislation (C-45). The witnesses are Sam Kamin (professor of marijuana law and policy, University of Denver); Michael Hartman (executive director, Colorado Department of Revenue); Marc-Boris St-Maurice (NORML Canada) and Abigail Sampson (NORML Canada)
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691490

Health committee – September 12, 2017 – Part 4
MPs continue their review of Bill C-45, the federal government’s proposal to legalize marijuana. Committee members hear from Marco Vasquez (retired Colorado police chief), Andrew Freedman (Colorado’s former director of marijuana coordination) Kevin Sabet (president, Smart Approaches to Marijuana), and Kristi Weeks (government relations director, Washington State Department of Health)
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691571

Health committee – September 13, 2017 – Part 1
The committee holds its third day of hearings on C-45, the federal government’s Cannabis Act.
Jonathan Page (chief executive officer, Anandia Labs), John Conroy (criminal defence lawyer) (president NORML Canada) and John Dickie (president, Canadian Federation of Apartment Associations) take part in a panel on the household cultivation of cannabis plants. Under the proposed bill, adults would legally be able to grow up to four plants per household.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691788

Health committee – September 13, 2017 – Part 2
MPs hear from Scott Bernstein (senior policy analyst, Canadian Drug Policy Coalition); Ian Culbert (executive director, Canadian Public Health Association); Dr. Christina Grant (member of the Canadian Paediatric Society’s adolescent health committee); Judith Renaud and Paul Renaud (respectively executive director and communications director, Educators for Sensible Drug Policy); and Peter A. Howlett (president)and Peter Vamos (executive director), both representing the organization Portage, which operates drug rehabilitation programs.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691799

Health committee – September 13, 2017 – Part 3
MPs hear from the following witnesses on Bill C-45: Amy Porath (director of research and policy, Canadian Centre on Substance Use and Addiction); Drug Free Kids Canada representatives Marc Paris (executive director) and William J. Barakett (member of advisory council); and Maude Chapados and François Gagnon (scientific advisors, Institut national de santé publique du Québec).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691801

Health committee – September 13, 2017 – Part 4
The following witnesses offer their viewpoints: Dr. Gabor Maté (addiction expert); Centre for Addiction and Mental Health representatives Benedikt Fischer (senior scientist, Institute for Mental Health Policy Research) and Bernard Le Foll (medical head, Addiction Medicine Service, Acute Care Program); Dr. Eileen de Villa (Toronto’s medical officer of health); Dr. Sharon Levy (director of the Adolescent Substance Abuse Program at Boston Children’s Hospital); as well as Michelle Suarly and Elena Hasheminejad (members of Ontario Public Health Association’s Cannabis Task Group).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691803

Health committee – September 14, 2017 – Part 1
The following witnesses discuss prevention, treatment, and low-risk use: Michael DeVillaer (assistant professor, department of psychiatry and behavioural neurosciences, McMaster University); Mark Kleiman (professor of public policy, Marron Institute of Urban Management, New York University; Lynda G. Balneaves, (medical and non-medical cannabis researcher) and Karey Shuhendler (policy advisor, policy, advocacy and strategy), both from with the Canadian Nurses Association; Dr. Serge Melanson (New Brunswick Medical Society); and Dr. Robert Strang (Nova Scotia’s chief medical officer of health).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009089

Health committee – September 14, 2017 – Part 2
Trina Fraser (lawyer and cannabis law expert) and Norm Keith (lawyer specializing in occupational health and safety) testify. Brenda Baxter, an official with the Department of Employment and Social Development’s workplace directorate, is the other witness.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009091

Health committee – September 14, 2017 – Part 4 (3)
Witnesses discuss labelling and packaging as the committee holds another hearing on the government’s cannabis legislation (C-45). The panellists are David Hammond (professor, University of Waterloo’s School of Public Health and Health Systems), Mike Hammoud (president Atlantic Convenience Stores Association), and Non-Smokers’ Rights Association representatives Melodie Tilson (director of policy) and Pippa Beck (senior policy analyst).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009092

Health committee – September 14, 2017 – Part 5 (4)
The witnesses for this panel are Steven Hoffman (professor, York University’s Faculty of Health), Beau Kilmer (co-director, RAND Drug Policy Research Centre), Kirk Tousaw, (criminal defence lawyer) (NORML Canada) and advocate for repealing cannabis prohibition), and Stephen Rolles (senior policy analyst, Transform Drug Policy Foundation).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52749534

Health committee – September 15, 2017 – Part 1
Ryan Vandrey (associate professor of psychiatry and behavioral sciences at Johns Hopkins University), Daniel Vigil (manager of marijuana health monitoring and research, Colorado Department of Public Health and Environment) and Dana Larsen (director, Sensible BC) are the witnesses for this panel.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009095

Health committee – September 15, 2017 – Part 2
The witnesses for this session are BC Compassion Club Society representatives Hilary Black (founder) and Marcel Vandebeek (administrator), Jonathan Zaid (executive director) and Daphnée Elisma (Quebec representative), who are both with the group Canadians for Fair Access to Medical Marijuana, and the Department of Health’s Jacqueline Bogden (assistant deputy minister, Cannabis Legalization and Regulation Branch).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009116


2017 NORML Canada Conference

By | Drug Policy, Events Calender, News Media

2017 has proven to be a historic year in cannabis history. Through our annual conference, we bring together experts from all walks of the cannabis space, to help educate and engage Canadians in open, productive and thoughtful dialogue.

norml.ca/2017-norml-canada-conference

Saturday, September 9th, 2017

11:00 AM – NORML Canada – Opening Address
11:15 AM – Jamie Shaw (MMJ Canada), Irie Sellkirk (Emblem), Dessy Pavlova (CSSDP/Lift), Amy Brown (Canndo) – Women and Cannabis Panel
12:30 PM – Britney Guerra – Cannabis Entrepreneurship – Challenges and Triumphs
1:30 PM Lunch Break
2:00 PM – Alison Gordon – Navigating Businesses into the Legal Cannabis Market
3:00 PM – Marcus Richardson (Bubbleman), Kevin Furet (Cannabis Wheaton), Jose Domingez (Canveda), Matt Rogge (7Acres) – Cannabis Growing- Personal, Patients and Large Production
4:00 PM – Dana Larsen – Keynote
5:00 PM – Marcus Richardson – Bubbleman Brand
6:00 PM – Jodie Emery – The Princess of Pot
7:00 PM – NORML Canada – Closing Day 1 Remarks – John Conroy

Sunday September 10th

11:00 AM – NORML Canada – Welcome
11:15 AM – MP Nathaniel Erskine Smith – Keynote
12:30 PM – David Schaefer (BHOGart) Safe Extraction Methods
1:30 PM – Lunch
2:00 PM – Alan Park – Canadian Comedian Cures Cancer with Cannabis Oil
3:00 PM – Adam Greenblatt (Canopy Growth), Matt Mernagh (Peace Naturals), John Fowler (Supreme), Kevin Furet (Cannabis Wheaton), Shega Youngson (Canopy Growth) – From Grey to Green – Transitioning Into the Legal Cannabis Market.
4:00 PM – Paul Lewin – Dispensaries- The Legal Challenges and Legalization
5:00 PM – Executive Directors of NIMCA – the National Indigenous Medical Cannabis Association
6:00 PM – Jonathan Zaid (CFAMM) – Cannabis and Driving
6:30 PM – NORML Canada Conference Closing Remarks – John Conroy

Liberal’s legalize cannabis legislation introduced

By | Drug Policy, News Media


Lift sponsor

 

We can’t help but feel the cannabis act is more decriminalization then legalization. Also of much concern is the criminal penalties and restrictions are much more harsher for cannabis then alcohol, tobacco and even many violent crimes.

Note: The impaired driving likely won’t hold up to constitutional challenges in the courts. calgary420.ca/pdf/driving/driving-impaired.pdf

Growing restricted to 4 plants per home and 1 meter height max. Tobacco cultivation limit is 15kg per year for each adult person living at the residence.
Note: Easy enough to control height with plant training.

 

April 13, 2017

Government of Canada news release (legalize cannabis legislation) (PDF)
calgary420.ca/pdf/cannabis_news-release.pdf

Government of Canada Cannabis Act (PDF)
calgary420.ca/pdf/cannabis_act.pdf



April 13, 2017

Emily Mertz, Web Producer – Global News Calgary

What do you think the legal minimum age to buy marijuana in Alberta should be?

See age poll left side after “City of Calgary” and before “Calgary 420 Cannabis Community”

globalnews.ca/news/3377809/alberta-cities-province-respond-to-federal-legislation-on-legalizing-marijuana

September 4, 2002 marks the release of the Senate Special Committee on Illegal Drugs: “Cannabis: Our Position for a Canadian Public Policy.” with a recommended 16 year old age limit for consuming cannabis.


April 13, 2017
Shaun Frenette – CTV Calgary News

Re: Concerns about youth and driving under proposed marijuana laws.

Cannabis and impaired driving – PDF document calgary420.ca/pdf/driving/driving-impaired.pdf

Re: Calgary Mayor Naheed Nenshi brain science comment:

The long term real world schizophrenia data from the nineteen sixties (1960s) to twenty sixteen (2016) shows no sufficient increases even thought cannabis consumption has sufficiently increased over the same time period (over 50 years).


April 15, 2017
Mike Blanchard – 660 News Radio

A local marijuana advocate is urging the Alberta government to keep pot out of liquor stores once the stuff becomes legal

www.660news.com/2017/04/15/marijuana-advocate-cautions-selling-weed-alongside-booze/


A Framework for the Legalization and Regulation of Cannabis in Canada

By | Drug Policy, News Media

The Final Report of the Task Force on Cannabis Legalization and Regulation


TFMLR Dec. 13, 2016

Table of Contents

Foreword

Executive Summary

Chapter 1: Introduction
Our mandate
The Canadian context
A global perspective
Setting the frame
Public policy objectives
Engagement process
Guiding principles

Chapter 2: Minimizing Harms of Use
Introduction: a public health approach
Minimum age
Promotion, advertising and marketing restrictions
Cannabis-based edibles and other products
THC potency
Tax and price
Public education
Prevention and treatment
Workplace safety

Chapter 3: Establishing a Safe and Responsible Supply Chain
Introduction
Production
Distribution
Retail
Personal cultivation

Chapter 4: Enforcing Public Safety and Protection
Introduction
Illegal activities
Personal possession
Place of use
Impaired driving

Chapter 5: Medical Access
Introduction
One system or two?
Access
Affordability
Products
Public safety
Evidence and research

Chapter 6: Implementation
Capacity
Oversight
Co-ordination
Communication

Annex 1: Biographies of Task Force on Cannabis Legalization and Regulation Members
Annex 2: Terms of Reference
Annex 3: Acknowledgements
Annex 4: Discussion Paper ‘Toward the Legalization, Regulation and Restriction of Access to Marijuana’
Annex 5: Executive Summary: Analysis of consultation input submitted to the Task Force on Cannabis Legalization and Regulation

http://healthycanadians.gc.ca/task-force-marijuana-groupe-etude/framework-cadre/index-eng.php


Access to Cannabis for Medical Purposes Regulations (ACMPR)

By | Drug Policy, News Media

Access to Cannabis for Medical Purposes Regulations (ACMPR)

Legalize Yes

August 24, 2016

Part 2 — Production for Own Medical Purposes and Production by a Designated Person

Part 2 of the ACMPR sets out a registration framework that allows for personal-use and designated production of cannabis (including cultivation of plants and alteration of products) for medical purposes.

Note: The majority of Part 2 incorporates the requirements of the former MMAR and relevant section 56 CDSA exemptions that respond to the decision in R. v. Smith with required modifications to incorporate the production, storage and possession of products other than dried marihuana or plants. New provisions that did not form part of the previous framework include the following:

•Proof of possession and registration can be demonstrated through a registration certificate issued by Health Canada.

• Starting materials (i.e. seeds and plants) can be obtained through licensed producers.

• Interim supply of cannabis (until plants are ready) can be obtained through licensed producers.

• Security measures do not need to be listed on the registration application, but those registering to possess and produce cannabis must declare that security measures are in place to keep plants and products secure.

• Information sharing provisions have been expanded to enable proactive sharing of information on registered persons with P/T health care licensing authorities.

Indoor & outdoor grams, plants and storage amounts.

Grams Per Day = Plant Count

Producing cannabis safety and security
Information bulletin: safety and security considerations when producing cannabis for your own medical purposes

Applications for Production for Own Medical Purposes and Production by a Designated Person
http://healthycanadians.gc.ca/alt/pdf/drugs-products-medicaments-produits/buying-using-achat-utilisation/cannabis-medical/access-acces/personal-production-personnelle/registration-form-formulaire-inscription-eng.pdf

Guidance Document – Completing the Production for Own Medical Purposes and Production by a Designated Person Registration Form
http://healthycanadians.gc.ca/drugs-products-medicaments-produits/buying-using-achat-utilisation/cannabis-medical/access-acces/personal-production-personnelle/registration-instructions-inscription-eng.php

Licensed dealer testing of cannabis produced by individuals
http://healthycanadians.gc.ca/drugs-products-medicaments-produits/buying-using-achat-utilisation/cannabis-medical/access-acces/personal-production-personnelle/licensed-dealer-testing-analyse-distributeurs-autorises-eng.php

August 11, 2016 Understanding ACMPR
Understanding the New Access to Cannabis for Medical Purposes Regulations

Complete ACMPR Regulations
http://www.gazette.gc.ca/rp-pr/p2/2016/2016-08-24/html/sor-dors230-eng.php

Contact Health Canada Cannabis for medical purposes
Email: omc-bcm@hc-sc.gc.ca
Toll Free Phone: 1-866-337-7705

More Cannabis for medical purposes services and information
Health Canada Cannabis for medical purposes


Government of Canada moves forward on Marijuana Legalization and Regulation

By | Drug Policy, News Media

Legalize Yes

Task force and public consultation to inform creation of a new system that will protect and inform Canadians
June 30, 2016
Ottawa, ON – Government of Canada – News Release

Participate by providing your input by completing the online consultation
Toward the Legalization, Regulation and Restriction of Access to Marijuana – Discussion Paper

or skip directly to participate in “online consultation”, locate the “Next” button at “Accessing Marijuana for Medical Purposes” “Privacy Notice”

or see “How to participate” “Provide feedback on minimizing harms of use by completing the “online consultation.” link above the “Previous” and “Next” buttons on the following five pages: 3.1 Minimizing harms of use, 3.2 Establishing a Safe and Responsible Production System, 3.3 Designing an appropriate distribution system, 3.4 Enforcing public safety and protection and 3.5 Accessing Marijuana for Medical Purposes

Contact,
Cannabis Legalization and Regulation Secretariat
Address locator 0602E
Ottawa, ON K1A 0K9

Email: cannabis@canada.ca


Note 3 Task Force members: Dr. Susan C. Boyd, Dr. Mark A Ware and Dr. Perry Kendall members of Liberal government “Task Force on Marijuana Legalization and Regulation”

Dr. Susan C. Boyd, Killer Weed: Marijuana Grow Ops, Media and Justice.
The Canadian Press — Dec. 25, 2013
Book by B.C. researcher says media, police not talking straight on pot

Susan C. Boyd, BC BookLook – April 17th, 2014 Reefer madness is governmental

Dr. Mark A Ware,
Executive Director of The Canadian Consortium for the Investigation of Cannabinoids (CCIC).

Dr. Perry Kendall, British Columbia Provincial Health Officer

November 10, 2014 Vancouver Sun
Dr. Perry Kendall reflects on 15 years as British Columbia’s Provincial Health Officer